XML 62 R35.htm IDEA: XBRL DOCUMENT v3.19.3
COMMITMENTS AND CONTINGENCIES (Tables)
9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contingent Consideration
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the nine months ended September 30, 2019 and 2018 is as follows (in thousands):
Nine Months Ended September 30, 2019
Contingent Consideration Liability Related to Acquisition of Arkis (See Note 2)
 
Contingent Consideration
 Liability Related to Acquisition of Derma Sciences
 
Long-term
 
Long-term
Balance as of January 1, 2019
$

 
$
230

Additions from acquisition of Arkis
13,100

 

Balance as of September 30, 2019
$
13,100

 
$
230


Nine months Ended September 30, 2018
 
Contingent Considerations
 Liabilities Related to Acquisition of Derma Sciences
 
Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.
 
Location in Financial Statements
 
 
Short-term
 
Long-term
 
Short-term
 
 
Balance as of January 1, 2018
 
$
315

 
$
1,387

 
$
22,478

 
 
Transfers from long-term to current portion
 
1,387

 
(1,387
)
 

 
 
Payments
 
(2,000
)
 

 
(19,000
)
 
 
Loss from change in fair value of contingent consideration liabilities
 
298

 
230

 
1,522

 
Selling, general and administrative
Balance as of September 30, 2018
 
$

 
$
230

 
$
5,000